LAURIE COLE: Open Payments
NPI 1407102296 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 24 payments from 11 companies in 2025. Trend: 2023 $693 · 2024 $479 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $217 |
| ABBVIE INC. | 5 | $97 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| BIOPROTECT MEDICAL, INC. | 1 | $48 |
| UROGEN PHARMA, INC. | 2 | $43 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| Endo USA, Inc. | 2 | $35 |
| PFIZER INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: ERLEADA, GEMTESA, BOTOX, LYNPARZA, BIOPROTECT BALLOON IMPLANT SYSTEM, LUPRON DEPOT, ADSTILADRIN, XIAFLEX.
Industry payments across PA — which companies pay providers there.
